Advertisement

Topics

IDT signs contract to supply Research Councils UK with custom oligonucleotides

11:12 EDT 10 Aug 2010 | BioPortfolio

Three year deal to advance UK scientific research

CORALVILLE, IA – July 12th 2010. Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, has signed a three year contract with Research Councils UK (RCUK) for the supply of synthetic oligonucleotides. RCUK coordinates the UK’s seven research councils, enhancing the overall impact and effectiveness of the research they fund. As one of the preferred suppliers of custom oligonucleotides, IDT’s expert production technologies will aid RCUK in delivering on the UK government’s objectives for science and innovation.

Each year RCUK invests approximately £2.5 billion in research, covering a broad spectrum of academic disciplines from medical and biological sciences, to astronomy, physics and chemistry. “We are delighted to name IDT as one of our preferred suppliers of custom oligonucleotides” commented Richard Fowles, Category Manager, RCUK. He continued, “IDT’s advanced manufacturing capabilities will provide the scientists we fund with a broad range of synthetic oligos to cover all of their requirements.”

“It is fantastic news that we have been selected as a preferred supplier by RCUK. We want researchers in the UK to benefit from IDT’s twenty-year commitment to tireless innovation and peerless quality in oligo synthesis. We can also use this opportunity to learn how IDT can best support research worldwide, as the science and application of synthetic biology advances,” commented Dr. Joseph A. Walder, IDT’s founder and CEO. With the ability to provide a complete range of oligos, from basic sequences to Ultramers, IDT offers the high fidelity synthesis of very long oligos up to 200 bases. Furthermore, proprietary synthesis systems and chemistries enable complete customization with any required modification(s).

IDT also provides a number of other molecular biology reagents, including custom synthetic genes and the free online SciTools, which provide all of the functionality required by scientists to optimize their oligo sequences. For more information on the complete range of IDT’s products, please visit www.idtdna.com.


About IDT
Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; and Leuven, Belgium. For more information, visit www.idtdna.com.
Integrated DNA Technologies

800-328-2661 (US & Canada)
+1 319-626-8400 (outside US)
productinfo@idtdna.com
www.idtdna.com


IDT enquiries
Integrated DNA Technologies
Lynette Brown – Advertising and Product Manager
t: +1 319-665-7208 e: lbrown@idtdna.com

Media enquiries Alto Marketing Limited
Carolyn Butchers – Science Writer
t: +44 (0)1489 557672 e:carolynb@alto-marketing.com

IDT enquiries Integrated DNA Technologies Lynette Brown – Advertising and Product Manager t: +1 319-665-7208 e: lbrown@idtdna.com Media enquiries Alto Marketing Limited Carolyn Butchers – Science Writer t: +44 (0)1489 557672 e:carolynb@alto-marketing.com NEXT ARTICLE

More From BioPortfolio on "IDT signs contract to supply Research Councils UK with custom oligonucleotides"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...